DE60014358D1 - USE OF ORG 33245 IN COMBINED INTERMITTENT HORMONE THERAPY AND CONCEPT PREVENTION - Google Patents

USE OF ORG 33245 IN COMBINED INTERMITTENT HORMONE THERAPY AND CONCEPT PREVENTION

Info

Publication number
DE60014358D1
DE60014358D1 DE60014358T DE60014358T DE60014358D1 DE 60014358 D1 DE60014358 D1 DE 60014358D1 DE 60014358 T DE60014358 T DE 60014358T DE 60014358 T DE60014358 T DE 60014358T DE 60014358 D1 DE60014358 D1 DE 60014358D1
Authority
DE
Germany
Prior art keywords
org
concept
prevention
hormone therapy
combined intermittent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60014358T
Other languages
German (de)
Inventor
Bennink Jan Coelingh
Hermanus Deckers
Peter Dols
Otto Orlemans
Gerardus Schoonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60014358D1 publication Critical patent/DE60014358D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Abstract

It has been found that the compound satisfying the structural formula (I) given below has a surprisingly good suitability for being administered intermittently. This particular compound therewith has the highly advantageous property that it can be used in the specific medical application of combined therapy with progestagen-only preparations.
DE60014358T 1999-04-29 2000-04-25 USE OF ORG 33245 IN COMBINED INTERMITTENT HORMONE THERAPY AND CONCEPT PREVENTION Expired - Lifetime DE60014358D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201390 1999-04-29
PCT/EP2000/003747 WO2000066129A2 (en) 1999-04-29 2000-04-25 Use of antiprogestagens in combined therapy

Publications (1)

Publication Number Publication Date
DE60014358D1 true DE60014358D1 (en) 2004-11-04

Family

ID=8240174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014358T Expired - Lifetime DE60014358D1 (en) 1999-04-29 2000-04-25 USE OF ORG 33245 IN COMBINED INTERMITTENT HORMONE THERAPY AND CONCEPT PREVENTION

Country Status (22)

Country Link
EP (1) EP1178807B1 (en)
JP (1) JP2002543136A (en)
KR (1) KR20010110807A (en)
CN (1) CN1349405A (en)
AT (1) ATE277618T1 (en)
AU (1) AU771059B2 (en)
BR (1) BR0010070A (en)
CA (1) CA2371635A1 (en)
CZ (1) CZ20013874A3 (en)
DE (1) DE60014358D1 (en)
HK (1) HK1041834A1 (en)
HU (1) HUP0201875A3 (en)
IL (1) IL145940A0 (en)
MX (1) MXPA01010976A (en)
NO (1) NO20015207L (en)
NZ (1) NZ514895A (en)
PL (1) PL351678A1 (en)
RU (1) RU2234321C2 (en)
SK (1) SK15502001A3 (en)
TR (1) TR200103116T2 (en)
WO (1) WO2000066129A2 (en)
ZA (1) ZA200108741B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009017990B4 (en) 2009-04-21 2022-04-07 Valeo Systèmes d'Essuyage flat wiper blade

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
MX9301121A (en) * 1992-03-02 1993-09-01 Schering Ag METHOD AND EQUIPMENT FOR ORAL CONTRACEPTION AND REGULATION OF MENSTRUATION WITH ESTROGEN / PROGESTIN / ANIPROGESTIN.
WO1993021926A1 (en) * 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
ZA935617B (en) * 1992-08-14 1994-03-07 Akzo Nv Antiprogestogen containing contraceptives.
CZ290697B6 (en) * 1996-06-25 2002-09-11 Akzo Nobel N. V. Peroral contraception system

Also Published As

Publication number Publication date
RU2234321C2 (en) 2004-08-20
TR200103116T2 (en) 2002-04-22
NZ514895A (en) 2004-06-25
HK1041834A1 (en) 2002-07-26
IL145940A0 (en) 2002-07-25
MXPA01010976A (en) 2002-07-22
EP1178807B1 (en) 2004-09-29
BR0010070A (en) 2002-01-15
AU771059B2 (en) 2004-03-11
SK15502001A3 (en) 2002-03-05
HUP0201875A3 (en) 2003-10-28
KR20010110807A (en) 2001-12-13
AU4120400A (en) 2000-11-17
CN1349405A (en) 2002-05-15
HUP0201875A2 (en) 2002-10-28
EP1178807A2 (en) 2002-02-13
JP2002543136A (en) 2002-12-17
NO20015207D0 (en) 2001-10-25
ATE277618T1 (en) 2004-10-15
WO2000066129A2 (en) 2000-11-09
WO2000066129A3 (en) 2001-04-19
CA2371635A1 (en) 2000-11-09
NO20015207L (en) 2001-10-25
PL351678A1 (en) 2003-06-02
CZ20013874A3 (en) 2002-06-12
ZA200108741B (en) 2003-07-23

Similar Documents

Publication Publication Date Title
DK2455083T3 (en) Pharmaceutical composition for dermal use comprising calcipotriol and betamethasone for the treatment of psoriasis
ATE320436T1 (en) DIMERIC PYRROLOBENZODIAZEPINES
ATE447947T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE
FI973828A (en) Compounds and compositions for administering the active ingredients
ITRM910922A1 (en) ANTI-PHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE TO PREPARE IT AND ITS THERAPEUTIC USE
ES2160707T3 (en) COMPOSITIONS THAT INCLUDE DETERIORATING AGENTS OF DNA AND P53.
CY1106156T1 (en) NEW USE OF BUDESONIDE AND FORMOTEPOL
DE69710065T2 (en) Androstene DERIVATIVES
EE9900036A (en) Novel compounds and compositions for the treatment of diseases associated with tryptase activity
EE04055B1 (en) Compounds and compositions for the treatment of diseases associated with serine protease activity, in particular tryptase activity, and their use
GB9907571D0 (en) Compounds
DE69832722D1 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR THE IMPROVEMENT AND TREATMENT OF ANEMIA IN HUMANS
DE60014358D1 (en) USE OF ORG 33245 IN COMBINED INTERMITTENT HORMONE THERAPY AND CONCEPT PREVENTION
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
ATE106732T1 (en) MEDICATION PREPARATION CONTAINING STIGMASTA-4-EN-3-ONE AND USE THEREOF.
ES2191825T3 (en) METAL SALTS OF BILIARY ACIDS WITH PHYSIOLOGICAL ACTION AND ITS USE IN THERAPY.
DE59502325D1 (en) Drug composition of S-lactic acid and its use
BR9810387A (en) (s) 3, 4, 5-trimethoxybenzoate of 2-methylamino-2-phenyl-n-butyl, and its application for the treatment of chronic pain
WO1999003509A3 (en) Pharmaceutical products containing triiodoaromats containing perfluoroalkyl groups, and the use thereof in the treatment of tumours and interventional radiology
DE60006284D1 (en) MEDICINAL PRODUCTS FOR TREATING CONVULSIVE STATES
ITMI941541A0 (en) CARBOXYMETHYLIDENECYCLOPTHIMIDAZOLE DERIVATIVES MANUFACTURING PROCEDURE OF THE DERIVATIVES AND THERAPEUTIC AGENTS CONTAINING THESE COMPOUNDS
ITRM920516A0 (en) COMPOSITION AND ITS USE FOR THE THERAPEUTIC TREATMENT OF DERMATIC DISEASES, PARTICULARLY PSORIASIS.
SE9803271D0 (en) A drug for well-being
IT1282951B1 (en) GASTRO-RESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND USE OF COLOSTRUM FOR THE TREATMENT OF INSOMNIA
ZA914000B (en) Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis

Legal Events

Date Code Title Description
8332 No legal effect for de